Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Long-Awaited Hypertension Guidelines Released at AHA

News Conference News AHA 2017

Long-Awaited Hypertension Guidelines Released at AHA

November 13, 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

October 16, 2017

‘J-Curve’ in Hypertension May Be Explained by Differences in Patient Characteristics

News Daily News

‘J-Curve’ in Hypertension May Be Explained by Differences in Patient Characteristics

September 26, 2017

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

News Daily News

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

July 20, 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

News Daily News

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Michael O'Riordan

March 16, 2017

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

TCTMD’s Top 10 Most Popular Stories for January 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

February 01, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.